Live Breaking News & Updates on நலு மருத்துவ|Page 2
Stay updated with breaking news from நலு மருத்துவ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Endeavour Vision Closes Endeavour Medtech Growth II, at USD375M Endeavour Vision, a venture capital and growth equity firm, closed the Endeavour Medtech Growth II (EMG II) LP fund, at USD 375m. Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices and high-net-worth individuals. Led by managing partners Bernard Vogel or Damien Teppy, Endeavour Medtech Growth II (EMG II) LP will invest in growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. The fund’s closing comes as the world begins to look towards post-pandemic life after more than 12 months in the grip of COVID-19, a crisis that has accelerated the adoption of new healthcare technologies including novel ways of delivering remote patient care. Underlying trends, such as ageing populations, chronic diseases and strained healthcare budgets will continue to fuel dem ....
Endeavour Vision closes Endeavour Medtech Growth II LP at USD 375m to invest in transformative healthcare technologies Endeavour Vision today announces the closing of Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices and high-net-worth individuals. EMG II LP builds on Endeavour Vision’s two decades of healthcare investing, which to date has included over USD 500 million invested in 42 companies - 21 of which have exited via an acquisition or IPO. ....
Press release content from Business Wire. The AP news staff was not involved in its creation. Endeavour Vision closes Endeavour Medtech Growth II LP at USD 375m to invest in transformative healthcare technologies April 22, 2021 GMT Endeavour Vision - Supporting medtech and digital health companies to shape the healthcare system. ST PETER PORT, Guernsey & GENEVA & MINNEAPOLIS (BUSINESS WIRE) Apr 22, 2021 Endeavour Vision today announces the closing of Endeavour Medtech Growth II (EMG II) LP at USD 375 million in capital commitments. The fund will pursue the same strategy as its predecessor: to support growth-stage medtech and digital health innovations that advance the standard of care and bring efficiencies to healthcare systems. Both new and returning investors supported EMG II LP, including public pension funds, multi-manager funds, family offices and high-net-worth individuals. EMG II LP builds on Endeavour Vision’s two decades of healthcare investing, wh ....
Nalu Medical Presents 3-Month Data on the nPower-AUS Study at the 2021 North American Neuromodulation Society Meeting Share Article The nPower-AUS study is a 12-month prospective, multi-center clinical trial scheduled to be completed later this year that evaluates the management of chronic intractable pain of the legs and/or back in 27 subjects implanted with the Nalu Neurostimulation System. These initial data suggest the Nalu device, an exceptionally small IPG, provides a robust treatment for patients in support of clinical efficacy. CARLSBAD, Calif. (PRWEB) January 15, 2021 Nalu Medical, Inc. (Nalu) announces 3-month clinical data from the ongoing Australia nPower-AUS Study were revealed today at the 2021 North American Neuromodulation Society (NANS) Annual Meeting. The nPower-AUS study is a 12-month prospective, multi-center clinical trial scheduled to be completed later this year that ....